Using the possibility offered by the aforementioned Royal Decree no. 4, and in order to protect the health of individual securities holders and the employees of the Company and others who are responsible for organizing the shareholders' meetings, the Board of Directors of the Company has decided to hold the annual and extraordinary shareholders' meetings behind closed doors without physical presence of the holders of securities of the Company, their proxyholders or others who have the right to attend the shareholders' meetings. This entails that:
The shareholders of the Company can exercise their voting rights only by way of a vote by mail or by proxy to the Chairman of the Board of Directors. Shareholders must provide their signed vote by mail form or proxy form to the Company at the latest on the fourth calendar day prior to the annual and extraordinary shareholders' meetings, i.e. on or before Monday
Holders of securities of the Company can only exercise their right to ask questions related to the items on the agenda of the general shareholders' meetings in writing. These written questions must be provided to the Company at the latest on the fourth calendar day prior to the annual and extraordinary shareholders' meetings, i.e. on or before Monday
The modalities of the aforementioned ways to participate in the annual and extraordinary shareholders' meetings are set out in the revised convening notice and relevant forms to vote by mail or by proxy. These documents can be consulted on the Company's website.
The Board of Directors would like to thank the securities holders for their understanding and cooperation.
--- END ---
More information:
Head of
e-mail rdegrave@biocartis.com
tel +32 15 631 729
mobile +32 471 53 60 64
(C) 2020 Electronic News Publishing, source